Direction Centrale du Service de Santé des Armées

defense.gouv.fr

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

92

Active

18

Phase 3

6

Total enrollment

46,199

Pipeline matrix

Showing 5 of 5 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Blood collection5
Blood sample collection2
Oxygen administration1
Blood sample1
Other biological sample collection1

Next readouts

  • 2026-08
  • 2026-12-31
  • 2028-04

Top conditions

  • SARS-CoV Infection6
  • Covid194
  • Sars-CoV23
  • COVID-193
  • Stress, Psychological2
  • Prostate Cancer2
  • Post-traumatic Stress Disorder2
  • Sleep Deprivation2

Frequently asked questions about Direction Centrale du Service de Santé des Armées

How many clinical trials does Direction Centrale du Service de Santé des Armées have on ClinicalTrials.gov?
Direction Centrale du Service de Santé des Armées is listed as the lead sponsor on 92 clinical trials in ClinicalTrials.gov, 18 of which are currently active (recruiting, enrolling, or ongoing).
How many of Direction Centrale du Service de Santé des Armées's trials are in Phase 3?
6 of Direction Centrale du Service de Santé des Armées's trials are in Phase 3, spread across 5 active drug programs.
What therapeutic areas does Direction Centrale du Service de Santé des Armées focus on?
Direction Centrale du Service de Santé des Armées's most-studied conditions on ClinicalTrials.gov are SARS-CoV Infection, Covid19, Sars-CoV2, COVID-19, Stress, Psychological.
When are Direction Centrale du Service de Santé des Armées's next clinical trial readouts?
Direction Centrale du Service de Santé des Armées has 3 upcoming primary-completion readouts tracked here; the soonest is “Screening for Individual Susceptibility Factors to Immersion Pulmonary Edema”, expected around 2026-08.